谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase II Trial of Trastuzumab Combined with Irinotecan in Patients with Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203 HERBIS-5): Final Results.

Junji Kawada,Daisuke Sakai,Yutaka Kimura,Motohiro Hirao,Kazuhiro Nishikawa,Naotoshi Sugimoto,Yoshio Oka,Shunji Endo,Yutaka Isozaki,Jin Matsuyama,Ryohei Kawabata,Tomono Kawase,Kazumasa Fujitani,Yukinori Kurokawa,Hisato Kawakami,Toshio Shimokawa,Taroh Satoh, Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)

Anticancer research（2025）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要